NVX Earnings & Financial Statements
Novonix Limited
$2.23
-$0.11(-4.70%)
37
Overall
60
Value
18
Tech
34
Quality
Market Cap
$48.00M
Volume
26.73K
52W Range
$2.37 - $36.60
Target Price
$5.00
NVX earnings and financial statements: Novonix Limited's income statement, balance sheet and cash flow statement, annual and quarterly.
NVX Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2022 |
|---|---|---|---|---|---|
| Revenue | $5.62M | $5.85M | $8.05M | $2.70M | $6.33M |
| Cost of revenue | $2.50M | $1.77M | $2.82M | - | - |
| Operating income | -$64.16M | -$57.98M | -$52.94M | -$15.79M | -$44.29M |
| EBITDA | -$92.70M | -$63.30M | -$52.22M | -$25.29M | -$65.63M |
| Net income | -$92.73M | -$63.40M | -$52.42M | -$27.86M | -$62.27M |
| EPS (diluted) | - | $-0.15 | $-0.09 | $-0.24 | $0.60 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2022 |
|---|---|---|---|---|---|
| Total assets | $282.92M | $226.10M | $246.68M | $277.42M | $439.56M |
| Total liabilities | $121.25M | $88.51M | $79.41M | $51.37M | $75.22M |
| Shareholders’ equity | $161.67M | $137.59M | $183.94M | -$138.60M | -$153.37M |
| Cash and equivalents | $79.87M | $42.56M | $78.71M | $55.71M | $128.94M |
| Long-term debt | $37.69M | $42.26M | $39.15M | $39.90M | $59.42M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2022 |
|---|---|---|---|---|---|
| Operating cash flow | -$42.20M | -$40.42M | -$36.23M | -$18.87M | -$40.35M |
| Capital expenditure | - | - | - | -$24.52M | -$115.60M |
| Free cash flow | -$102.37M | -$70.30M | -$55.41M | -$43.38M | -$155.96M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NVX | $2.23 | -4.7% | 26.73K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |